SentoClone®SentoClone® activates the body’s own immune system to combat cancer. The treatment is conducted with the patient’s own white blood cells.

In connection with the tumour or metastasis being operated, the lymph nodes that are in direct contact with the tumour (the so-called sentinel nodes) are also taken out. The sentinel nodes contain the white blood cells that have learned to recognise the tumour as something foreign.

How does the method work?

These white blood cells, which react to tumour cells, are isolated and cultivated in SentoClone AB’s laboratory. Cultivating the cells takes about a month, and during that time the white blood cells that recognise the tumour multiply many times over. The time the cell culture spends in the laboratory can be viewed as a “boot camp” for the tumour reactive white blood cells. That the white blood cells find it hard to thrive in the patient’s body is because the tumour creates an unfavourable environment for the immune system.

The white blood cells are given back to the patient by means of a simple transfusion and once in the patient’s body they can seek out and combat the tumour cells.

Because the treatment is conducted using the patient’s own white blood cells the method is expected not to cause any significant side effects – an expectation that our research so far supports.

SentoClone®

Last Updated Tuesday, 01 June 2010 10:36